During the processes of everolimus-inducing ferroptosis in breast cancer cells, an everolimus-related protein named FK506-binding protein 1A (FKBP1A) negatively regulates the SLC3A2 expression to promote anti-proliferation effect of Th9 lymphocytes [75]. Here, FKBP1A is linked to breast cancer.